ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988

Administration Plans to Stop Paying Advisors; NIH, HHS to Make Protest

May 6, 1983

Nobel In Chemistry For Work Linking Carbon Atoms

October 8, 2010

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

President Signs Supplemental Funding For NIH And FDA.

July 11, 2008

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974